AMGN · CUSIP 031162100
Amgen Inc
Reported by 5 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 5
- Average portfolio weight
- 1.2%
- Combined reported value
- $66.3M
- Research group
- 79
5 of the 79 superinvestors Shameless Cloning tracks reported Amgen Inc (AMGN) in their Q2 2026 13F filings, worth $66.3M combined, at an average 1.2% of their portfolios. The largest positions by portfolio weight belong to Torray Funds (2.9%), David Katz (2.9%), Steven Check (0.1%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Torray FundsTorray Investment Partners LLC | 2.9% | $21.6M |
| David KatzMATRIX ASSET ADVISORS INC/NY | 2.9% | $35.4M |
| Steven CheckCHECK CAPITAL MANAGEMENT INC/CA | 0.1% | $2.8M |
| Mairs & Power FundsMAIRS & POWER INC | 0.0% | $1.8M |
| Dodge & Cox FundsDodge & Cox | 0.0% | $4.6M |